The Hong Kong-listed company C-MER MEDICAL (03309) has announced a share repurchase transaction.
On July 8, 2026, the company executed a buyback, utilizing approximately HK$147,700 to acquire 148,000 of its own shares.
The Hong Kong-listed company C-MER MEDICAL (03309) has announced a share repurchase transaction.
On July 8, 2026, the company executed a buyback, utilizing approximately HK$147,700 to acquire 148,000 of its own shares.
Comments